by Deliberato Law Center | Aug 16, 2023 | Estate Planning, Estate Planning Education, Medicaid
If you’re past the age of retirement, planning for the future is never more important. While you may be in perfect health now, things can change quickly as you get older, and it’s essential that you be prepared. When it comes to estate planning, accounting for all...
by Deliberato Law Center | Aug 3, 2023 | Estate Planning, Medicaid
Medicaid can be a great way for people with lower incomes to ensure that their health needs are met. In addition, it can be a useful tool for preparing for your health needs in your later years. Should something happen to you, and you need to stay in a nursing home,...
by Deliberato Law Center | Nov 8, 2022 | Elder Law, Estate Planning, Medicaid
When the time comes to choose a home care provider for an aging parent, you don’t want to leave anything to chance. The amount of elder care and senior services is extremely wide-ranging, and you need to make sure you select the type and level of care that best suits...
by Deliberato Law Center | Oct 17, 2022 | Elder Law, Estate Planning, Medicaid
An estate plan is more than just preparing for death, it also provides disability protection through what is called special needs planning. This can help your family be protected if you ever become unable to care for yourself, pay your bills or manage your own...
by Deliberato Law Center | Mar 30, 2022 | Estate Planning Education, Medicaid, Uncategorized
Numerous studies have shown that Americans’ greatest fear regarding retirement is running out of money. Even so, myths abound about planning for retirement, Social Security, the cost of medical care, and more. Let’s explore the reality behind some of the most common...
by Deliberato Law Center | Jan 27, 2022 | Elder Law, Estate Planning Education, Medicaid, Uncategorized
The Food and Drug Administration (FDA) has approved a drug purported to slow the progress of Alzheimer’s disease. However, the decision is not without controversy. A recent article by AARP explores this subject in some detail. Here is a synopsis. The drug, Aducanumab...
Recent Comments